Microbiome community

The **microbiome community** refers to the entire assemblage of microorganisms—including bacteria, archaea, fungi, protists, and viruses—living together in a defined environment or habitat, such as the human gut, skin, or other ecological niche[1][3]. This term encompasses not just the organisms themselves but also their collective genome, interactions, and biochemical activities[1]. The composition and function of a microbiome community can strongly influence host physiology, including digestion, immune defense, metabolic regulation, and resistance to pathogens[3]. While the humans' gut microbiome is a major focus of research, microbiome communities are found in all environments. The microbiome community is not a single molecular target, receptor, or protein but a complex multispecies ecosystem, making it distinct from canonical drug targets like enzymes or receptors. However, new therapeutics increasingly seek to modulate these communities through live biotherapeutics, selective antimicrobials, pre- and probiotics, and fecal microbiota transplantation[2][4]. The complexity and dynamism of the microbiome present both opportunities and challenges for drug development, particularly regarding safety, reliability, and mechanistic understanding. **Note:** "Microbiome community" is not a canonical molecular target like a receptor, enzyme, or transporter, but rather an ecological and systems-level concept. It is not appropriate to treat it as a single molecular target[1][2][3], thus is_incorrect=true for a structured target listing.

Other names

Microbial communityMicroorganism communityMicrobial ecosystemMicrobial consortium

Modulation of microbial composition; Immunomodulation; Suppression or exclusion of pathogens; Restoration of metabolic function; Engineering of metabolic or signaling pathways in microbial consortia[2][4]